相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Curcumin potentiates the antitumor effects of 5-FU in treatment of esophageal squamous carcinoma cells through downregulating the activation of NF-κB signaling pathway in vitro and in vivo
Fang Tian et al.
ACTA BIOCHIMICA ET BIOPHYSICA SINICA (2012)
Natural Products for Cancer-Targeted Therapy: Citrus Flavonoids as Potent Chemopreventive Agents
Edy Meiyanto et al.
ASIAN PACIFIC JOURNAL OF CANCER PREVENTION (2012)
Purely aqueous PLGA nanoparticulate formulations of curcumin exhibit enhanced anticancer activity with dependence on the combination of the carrier
K. Lekha Nair et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2012)
Modulatory effects of curcumin on multi-drug resistance-associated protein 5 in pancreatic cancer cells
Yan Li et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2011)
A phase I/II study of gemcitabine-based chemotherapy plus curcumin for patients with gemcitabine-resistant pancreatic cancer
Masashi Kanai et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2011)
Akt is upstream and MAPKs are downstream of NF-κB in paclitaxel-induced survival signaling events, which are down-regulated by curcumin contributing to their synergism
Smitha V. Bava et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2011)
Molecular evidences for the chemosensitizing efficacy of liposomal curcumin in paclitaxel chemotherapy in mouse models of cervical cancer
C. N. Sreekanth et al.
ONCOGENE (2011)
Drug Combination Studies and Their Synergy Quantification Using the Chou-Talalay Method
Ting-Chao Chou
CANCER RESEARCH (2010)
Nicotine-induced survival signaling in lung cancer cells is dependent on their p53 status while its down-regulation by curcumin is independent
Vineshkumar T. Puliyappadamba et al.
MOLECULAR CANCER (2010)
Modulation of thymidilate synthase and p53 expression by HDAC inhibitor vorinostat resulted in synergistic antitumor effect in combination with 5FU or raltitrexed
Elena Di Gennaro et al.
CANCER BIOLOGY & THERAPY (2009)
cIAP1, cIAP2, and XIAP Act Cooperatively via Nonredundant Pathways to Regulate Genotoxic Stress-Induced Nuclear Factor-κB Activation
Hyung-Seung Jin et al.
CANCER RESEARCH (2009)
Liposome encapsulation of curcumin and resveratrol in combination reduces prostate cancer incidence in PTEN knockout mice
Narayanan K. Narayanan et al.
INTERNATIONAL JOURNAL OF CANCER (2009)
A Case of Wernicke's Encephalopathy Following Fluorouracil-based Chemotherapy
In Jeong Cho et al.
JOURNAL OF KOREAN MEDICAL SCIENCE (2009)
Synergistic Role of Curcumin With Current Therapeutics in Colorectal Cancer: Minireview
Bhaumik B. Patel et al.
NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL (2009)
5-Fluorouracil combined with apigenin enhances anticancer activity through induction of apoptosis in human breast cancer MDA-MB-453 cells
Eun Jeong Choi et al.
ONCOLOGY REPORTS (2009)
Paeoniflorin suppress NF-κB activation through modulation of IκBα and enhances 5-fluorouracil-induced apoptosis in human gastric carcinoma cells
Hao Wu et al.
BIOMEDICINE & PHARMACOTHERAPY (2008)
Curcumin inhibits proliferation, invasion, angiogenesis and metastasis of different cancers through interaction with multiple cell signaling proteins
Ajaikumar B. Kunnumakkara et al.
CANCER LETTERS (2008)
Synergistic antitumor effect of S-1 and the epidermal growth factor receptor inhibitor gefitinib in non-small cell lung cancer cell lines: role of gefitinib-induced down-regulation of thymidylate synthase
Takafumi Okabe et al.
MOLECULAR CANCER THERAPEUTICS (2008)
Liposomal curcumin with and without oxaliplatin: effects on cell growth, apoptosis, and angiogenesis in colorectal cancer
Lan Li et al.
MOLECULAR CANCER THERAPEUTICS (2007)
Violacein synergistically increases 5-fluorouracil cytotoxicity, induces apoptosis and inhibits Akt-mediated signal transduction in human colorectal cancer cells
LL Kodach et al.
CARCINOGENESIS (2006)
Curcumin suppresses the paclitaxel-induced nuclear factor-κB pathway in breast cancer cells and inhibits lung metastasis of human breast cancer in nude mice
BB Aggarwal et al.
CLINICAL CANCER RESEARCH (2005)
Nuclear factor-κB inhibitors as sensitizers to anticancer drugs
C Nakanishi et al.
NATURE REVIEWS CANCER (2005)
Sensitization of taxol-induced apoptosis by curcumin involves down-regulation of nuclear factor-κB and the serine/threonine kinase Akt and is independent of tubulin polymerization
SV Bava et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Modulation of 5-fluorouracil cytotoxicity through thymidylate synthase and NF-κB down-regulation and its application on the radiolabelled iododeoxyuridine therapy on human hepatoma cell
HE Wang et al.
BIOCHEMICAL PHARMACOLOGY (2005)
Thymidylate synthase as an oncogene: A novel role for an essential DNA synthesis enzyme
L Rahman et al.
CANCER CELL (2004)
Roles of the PI-3K and MEK pathways in Ras-mediated chemoresistance in breast cancer cells
W Jin et al.
BRITISH JOURNAL OF CANCER (2003)
Thymidylate synthase inhibitors as anticancer agents: from bench to bedside
E Chu et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2003)
5-Fluorouracil: Mechanisms of action and clinical strategies
DB Longley et al.
NATURE REVIEWS CANCER (2003)
Disulfiram-mediated inhibition of NF-κB activity enhances cytotoxicity of 5-fluorouracil in human colorectal cancer cell lines
WG Wang et al.
INTERNATIONAL JOURNAL OF CANCER (2003)
Constitutive nuclear factor-kappa B mRNA, protein overexpression and enhanced DNA-binding activity in thymidylate synthase inhibitor-resistant tumour cells
W Wang et al.
BRITISH JOURNAL OF CANCER (2003)
Activation of nuclear factor-κB during doxorubicin-induced apoptosis in endothelial cells and myocytes is pro-apoptotic:: the role of hydrogen peroxide
SW Wang et al.
BIOCHEMICAL JOURNAL (2002)
Distribution of mutations in human thymidylate synthase yielding resistance to 5-fluorodeoxyuridine
H Kawate et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Induction of thymidylate synthase as a 5-fluorouracil resistance mechanism
GJ Peters et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2002)
Activation of AKT/PKB in breast cancer predicts a worse outcome among endocrine treated patients
G Pérez-Tenorio et al.
BRITISH JOURNAL OF CANCER (2002)
Antisense-induced down-regulation of thymidylate synthase and enhanced cytotoxicity of 5-FUdR in 5-FUdR-resistant HeLa cells
PJ Ferguson et al.
BRITISH JOURNAL OF PHARMACOLOGY (2001)
Synergistic efficacy of 3n-butyrate and 5-fluorouracil in human colorectal cancer xenografts via modulation of DNA synthesis
RA Bras-Gonçalves et al.
GASTROENTEROLOGY (2001)
Mammalian MAP kinase signalling cascades
LF Chang et al.
NATURE (2001)
分享论文
